Jeb Williams
Orthopaedic Surgery · Tupelo, MSNPI 1114311198
Payments from drug & device makers
What this record shows
This record is dominated by education: $16,260 of the $17,843 with a category attached, or 91.1%. Smith+Nephew accounts for 84.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $8,940 and has fallen 95.5% since, to $405 in 2025.
Across 27 payments — averaging $660.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$15K
- ALON Medical Technology$1K
- Zimmer Biomet$501
- Orthalign Inc$352
- Johnson & Johnson$233
- Sanara Medtech Inc.$150
- plus $348 from 6 others
What the payments were for
- Food & beverage$1,5839%
- Education$16,26091%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 2 | $15,000 |
| ALON Medical Technology | 1 | $1,260 |
| Zimmer Biomet | 6 | $501 |
| Orthalign Inc | 3 | $352 |
| Johnson & Johnson | 3 | $233 |
| Sanara Medtech Inc. | 2 | $150 |
| Stryker(2 entities) | 2 | $136 |
| Cumberland Pharmaceuticals, Inc. | 1 | $66 |
| Innovation Technologies Inc | 2 | $56 |
| Endo Pharmaceuticals Inc. | 3 | $48 |
| Bioventus LLC | 1 | $23 |
| Endo USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORTHALIGN PLUS$261
- AccuFill$144
- ROSA-Knee$139
- CellerateRx$132
- MAKO$125
- ATTUNE$123
How this compares
$17,843 in reported general payments places this provider in the 75th percentile of 170 orthopaedic surgery providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 128 | $1,806 |
| Pregabalin | 89 | $1,417 |
| Cefadroxil | 200 | $1,098 |
| Ibuprofen | 145 | $992 |
| Oxycodone Hcl | 130 | $840 |
| Ondansetron Hcl | 86 | $358 |
| Omeprazole | 95 | $354 |
| Cyclobenzaprine Hcl | 18 | $283 |
| Meloxicam | 109 | $278 |
| Celecoxib | 34 | $240 |
| Prednisone | 99 | $192 |
| Tramadol Hcl | 52 | $187 |
| Hydromorphone Hcl | 65 | $101 |
| Amoxicillin | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tupelo
- George van OstenTupelo$322K
- Stephen SouthworthTupelo$160K
- William StewardTupelo$55K
- Rowland RobersonTupelo$43K
- Jacob SmitheyTupelo$17K
- Mary GibsonTupelo$10K
- Bryan FaganTupelo$8K
- Matthew GravesJackson$1.2M
- Edward HobgoodJackson$267K
- Hanna MitiasNew Albany$249K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.